GCTCAAACAGGGTCTGGGAAG GGTTGATCAGTTCTCGAG

PRIMERS USED FOR RT-PCR
*: "sq" and "q" indicate that primer pairs were used for sq-and q-RT-PCR, respectively.
Vector construction
Unless otherwise noted, the restriction enzymes and DNA modifying enzymes used in this study were obtained from New England Biolabs (NEB; Ipswich, MA), and the oligonucleotides used were synthesized by Invitrogen (Carlsbad, CA). PCR was carried out with Phusion DNA polymerase (NEB) to introduce new restriction enzyme sites at the ends of PCR products. The DNA constructs used as templates for PCR were kindly provided by Dr. William L. Stanford, University of Toronto, Ontario, Canada.
The CAG promoter (Niwa et al., 1991) was obtained from pCXeCFP (Hadjantonakis et al., 2002) by double-digestion with SalI and EcoRI and cloned into pBluescript II KS(-), which was designated pBS_CAG. Then, a bovine growth hormone polyadenylation signal was obtained from ROSAb-gal (Friedrich and Soriano, 1991) by XbaI digestion and cloned into pBS_CAG. The resulting plasmid was named pCAG_BGHpA, which has EcoRI, PstI, SmaI and BamHI sites uniquely available. The puromycin-resistant gene (Puro r ) was PCR-amplified with EcoRI-Puro-F (5'-ACG AAT TCC ATG ACC GAG TAC AAG CCC ACG G-3') and XbaI-Puro-R (5'-AAT CTA GAT CAG GCA CCG GGC TTG CG-3') as primers using pEGFP-IRES-Puro (Clontech, Mountain View, CA) as a template. This product was cloned into pIRES-Neo (Clontech), which had been digested with EcoRI and XbaI. This plasmid was designated pPuro. Then, using pCXeCFP as a template, ECFP was PCR-amplified and cloned into pPuro digested with EcoRV and EcoRI to generate ECFP fused with the puromycin-resistant gene. The primers used were as follows: EcoRV-ECFP-F, 5'-ATG ATA TCG CCA CCA TGG TGA GCA-3'; EcoRI-ECFP-Fus-R, 5'-TCG AAT TCT TGT ACA GCT CGT CC-3'. ECFP expression and puromycin resistance were functionally validated by transfection of the construct into Phoenix cells (Pear et al., 1993) by the CaPO4 method. Because XbaI-Puro-R introduced a sequence motif for Dam methylation, the ECFP-Puro cassette was further PCR-amplified with EcoRV-ECFP-F and XbaI-Puro-R primers. After digestion with EcoRV and XbaI, followed by performing a fill-in reaction using the Klenow fragment (Invitrogen), the ECFP-Puro cassette was blunt-end ligated with SmaI-digested pCAG_BGHpA. The resulting vector was designated pCAG_CFPuro.
To clone the self-cleaving peptide T2A (Szymczak et al., 2004) , sense and antisense oligonucleotides encoding the T2A peptide were designed, as follows: EcoRI-2A-S1, 5'-AAT TCA AGA GCT AAA AGA GAG GGC AGA GGA AGT CTG CTA-3'; 2A-EcoRI*-S2, 5'-ACA TGC GGT GAC GTC GAG GAG AAT CCT GGC CCA GGA TCA GGA-3'; 2A-EcoRI*-AS1, 5'-AAT TTC CTG ATC CTG GGC CAG GAT TCT CCT CGA CGT CAC C-3'; EcoRI-2A-AS2, 5'-GCA TGT TAG CAG ACT TCC TCT GCC CTC TCT TTT AGC TCT TG-3' [Integrated DNA Technologies (IDT) Coralville, IA]. These oligonucleotides were self-assembled in 0.3 x SSC (50 mM Na + ) at 65 ºC, overnight, and cloned into EcoRI-digested pCAG_CFPuro. This T2A adaptor contains compatible ends with EcoRI, although the one at the 3' end (*) was mutated, such that the EcoRI site at the 5' end remained unique in the final construct, pCAG_T2APuro. Rhox6 was first PCR amplified from cDNA and cloned into pBluescript II KS (-) to assure that the cDNA encoded Rhox6 specifically and not Rhox9. The cDNA used was prepared using total RNA extracted from the extraembryonic tissues of embryos at E9.5-10.5 from matings of CD1 mice. The primers used were as follows: EcoRV-Rhox6-F, 5'-ATG ATA TCG GAA GCC TCT TCG GGA GCA GCG TC-3', and EcoRI-Rhox6-R, 5'-GCG AAT TCA GAA TGC TCA TCT TTA TTG CTG AAA TAA TTG TAG AG-3'. After the sequence was validated, the protein-coding region of Rhox6 was PCR-amplified, then cloned into pCAG_T2APuro digested with EcoRI. The primers used for this step were as follows: EcoRI-Rhox6-F, 5'-GGA ATT CGC CAC CAT GGA AAC TCC TCA AGA CAG-3', and EcoRI-Rhox6-R, 5'-AAG AAT TCG GAG AGT CGC TCT GGG GAA GAG G-3' (IDT). The forward primer introduced Kozak's consensus sequence for strong translational initiation (GCC ACC ATG G) (Kozak, 1987) .
DsRedT3 was PCR-amplified using MST-B (Bevis and Glick, 2002; Vintersten et al., 2004) as a template and cloned into pBS_ SAGtxVenus, which was used to build pGTIV (Tanaka et al., 2008) . The primers used were as follows: EcoRV-Red-F, 5'-ATG ATA TCG CCA CCA TGG CCT CCT C-3'; EcoRI-Red-Fus-R, 5'-TTG AAT TCA GGA ACA GGT GGT GGC GG-3'. The resulting plasmid was designated pBS_SAGtxDsRedT3. Then, the T2A_Puro r cassette from pCAG_T2APuro was cloned between EcoRI and XbaI sites in pBS_SAGtxDsRedT3. Finally, the Gtx_DsRedT3_T2A_Puro r cassette was digested with NsiI and BamHI and then cloned into pCAG_T2APuro digested with PstI and BamHI. This vector was designated pCAG_DsRedT2AP (Chowdhury et al., 2010) .
To build a construct that expressed short-hairpin (sh) RNA (Brummelkamp et al., 2002) , the human H1 (hH1) promoter in pcDNA_RasGap (Kunath et al., 2003) was first PCR-amplified with the following primers: EcoRV-XhoI-hH1-F, 5'-GCG ATA TCT CGA GCA ATA TTT GCA TGT CGC TAT GTG-3'; SalI-HK-hH1-R, 5'-ATG TCG ACA AGC TTA AGG TAC CGA GTG GTC TCA TAC AG-3'. Next, pCAG_CFPuro was digested with KpnI, which was blunt-ended with mung bean nuclease and further digested with XhoI. This was used to clone PCR-amplified hH1 digested with EcoRV and SalI. The resulting vector was designated phH1CCP. Oligonucleotides for shRNA expression were cloned between KpnI and HindIII sites downstream of hH1 (underlined in SalI-HK-hH1-R).
phH1CCP was further modified as follows. site (CCATGG), a modified T2A cassette was inserted between the EcoRI and NcoI sites. Then, the T2A_Bsd r cassette digested with EcoRI and BamHI was cloned into phH1CCP. This plasmid was designated phH1C2AB. Finally, the Gtx_DsRedT3 cassette was obtained from pCAG_DsRedT2AP by EcoRI-digestion and cloned into phH1C2AP. The resulting vector was designated phH1CRB.
To select target regions for shRNA expression, lists of candidate sites were obtained using the following web-based tools: siDESIGN Center (http://www.dharmacon.com/designcenter/designcenterpage.aspx); siRNA Target Designer (http://www.promega.com/siRNADesigner/program/); siRNA Target Finder (http://www.ambion. com/techlib/misc/siRNA_finder.html); BLOCK-iT TM RNAi Designer (https://rnaidesigner.invitrogen.com/rnaiexpress/). The specificity of the target sequence was validated using the Ensembl Genome Browser. A scrambled oligonucleotide sequence was designed as a negative control and showed matches with three intronic regions. According to their specificity, three target sites were selected for each Rhox gene, and corresponding oligonucleotides were designed (IDT). These oligonucleotides were self-assembled in 0.3 x SSC (50 mM Na + ) at 65 ºC overnight and ligated with phH1CCP and phH1CRB, which had been double-digested with KpnI and HindIII. Their nucleotide sequence was validated by sequencing.
To evaluate the levels of knockdown obtained, mouse ESCs were transiently transfected with each shRNA expression vector (phH1CCP) by FuGene HD (Roche Applied Science, Indianapolis, IN). Two days after selection with 2 mg/ml puromycin (InvivoGen, San Diego, CA), total RNA was extracted (Chomczynski and Sacchi, 1987 ) and used to synthesize cDNA. The oligonucleotide sequences that induced specific knockdown of their targets are listed below. Only sequences for sense strands are shown. For oligonucleotides against Rhox6 or Rhox9, the position of the corresponding nucleotide sequence is shown by counting the "A" in the translational initiation codon (ATG) as 1: for scrambled1-S, 5'-CGG TTG TGG TGC GGA ACA CA-3', there are three hits with intronic regions with e-values of 0.32 or greater; for shRhox6-627S (627-647), 5'-CCA GGA GAG TGC TGA TGT TCT G-3', the e-value for the match with Rhox6 is 0.0013, and there are seven additional matches with either non-coding genomic or intronic regions with e-values of 0.32 or greater; for shRhox9-652S (652-670), 5'-CCT GCC ACC GAT TAC AGA GA-3', the e-value for the match with Rhox9 is 0.021, and there is another match with an intronic region with an e-value of 4.8; for shRhox6&9-542S (542-560 in Rhox6), 5'-CGG AGG GAT CTT GCA CGA TG-3', the e-value for the match with Rhox6 and Rhox9 is 0.021, and there is another match with a non-coding genomic region with an e-value of 1.3. The closer the E-value is to zero, the more significant the similarity is.
